27
total announcements
543654.BO · 15 min delayed
Global Health Ltd
Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, with no unpublished price sensitive information to be shared.
Global Health Ltd
Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, where the company's management will meet investors and analysts. The meeting is subject to change due to unforeseen circumstances.
Global Health Ltd
Global Health Ltd (MEDANTA) has announced an institutional investor meet on August 31, 2026, in Noida, to be held in person. The meeting is organized by Prabhudas Lilladher Capital, and no unpublished price-sensitive information will be shared.
Global Health Ltd
Global Health Ltd (MEDANTA) has scheduled an analyst/institutional investor meeting on August 26-27, 2026, with Motilal Oswal Financial Services, without sharing unpublished price-sensitive information.
Global Health Ltd
Global Health Ltd has announced an institutional investor meet, scheduled for August 26 and 27, 2026, where the company's management will meet with investors and analysts. The meeting will be held in physical mode, and no unpublished price-sensitive information will be shared.
Global Health Ltd
Global Health Ltd has published a newspaper advertisement confirming the dispatch of AGM notice and annual report for the financial year 2025-26.
Global Health Ltd
Global Health Ltd has dispatched a letter to shareholders providing the weblink of Annual Report for the FY 2025-26, as per SEBI Listing Regulations. The 22nd Annual General Meeting (AGM) is scheduled to be held on September 16, 2026, through Video Conference (VC) / Other Audio-Visual Means (OAVM).
Global Health Ltd
Global Health Ltd, the parent company of Medanta, a multi-specialty tertiary care provider, has released its Business Responsibility and Sustainability Report for the financial year 2025-26, along with a Reasonable Assurance Report. The report highlights the company's corporate identity, business activities, operational footprint, workforce profile, and holding/subsidiary structure. The report also sets out the company's linkage with capitals, including patients, employees, shareholders, financial capital, human capital, and manufactured capital.
Global Health Ltd
Global Health Ltd has submitted its Annual Report for the Financial Year 2025-26, along with the Business Responsibility and Sustainability Report (BRSR) and Notice of the 22nd Annual General Meeting (AGM).
Global Health Ltd
Global Health Ltd has announced its 22nd Annual General Meeting (AGM) to be held on September 16, 2026, through video conferencing. The meeting will consider and adopt the audited standalone financial statements for the financial year ended March 31, 2026, and the audited consolidated financial statements. The meeting will also declare a final dividend of ₹0.50 per equity share for the financial year ended March 31, 2026.
Global Health Ltd
Global Health Ltd (MEDANTA) has announced a schedule for an analyst/institutional investor meeting on August 21, 2026, to be held virtually with FIRST RAY CAPITAL in Singapore. No unpublished price-sensitive information will be shared.
Global Health Ltd
Global Health Ltd announced the pre-advertisement of its 22nd Annual General Meeting scheduled for September 16, 2026, through video conferencing or other audio-visual means. The company also invited e-tenders for the construction of cement concrete roads in Nagpur.
Global Health Ltd
Global Health Ltd (Medanta) has released the transcript of its Q1 FY27 Earnings Conference Call, highlighting its focus on clinical excellence, patient-centric care, and operational growth.
Global Health Ltd
Global Health Ltd has intimated under Regulation 30 of SEBI Listing Regulations 2015 that an audio recording of the earnings conference call held on July 31, 2026, is available on their website. The call was hosted by JM Financial for the First Quarter ended June 30, 2026 financial results.
Global Health Ltd
Global Health Ltd has published unaudited financial results for the first quarter ended June 30, 2026, in accordance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Global Health Ltd
Global Health Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and has declared a final dividend of Rs. 0.50 per equity share for the financial year 2025-26. The company has also appointed a new Chief Digital Officer and increased the proposed bed capacity of its upcoming hospital at Guwahati from 400 to 650 beds.
Global Health Ltd
Global Health Ltd (MEDANTA) has announced its Q1 FY2027 results, with revenue growth of 26% y-o-y, primarily led by increase in patient volumes and realization. EBITDA (ex-Noida) grew 23.9% y-o-y to INR 3,201 with improved margins of 25.8% in Q1 FY27. Noida hospital generated Total Income of INR 855 million and EBITDA loss of INR 49 million in Q1 FY27, compared to total income of INR 525 million and EBITDA loss of INR 236 million reported in Q4 FY26.
Global Health Ltd
Global Health Ltd (Medanta) reported its Q1 FY2027 results, with a 26.2% y-o-y growth in total income to INR 13,262 million and a 23.5% y-o-y growth in EBITDA to INR 3,153 million. The company added 72 new beds across its network, including 51 in Noida, and witnessed a 27.7% y-o-y increase in in-patient count and a 34.5% y-o-y increase in out-patient count.
Global Health Ltd
Global Health Ltd announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The company's board of directors approved the results, which include a revised construction plan for its upcoming hospital at Guwahati, increasing the proposed bed capacity from 400 to 650 beds. The trading window will open after 48 hours from the declaration of the results.
Global Health Ltd
Global Health Ltd has announced the fixation of record date for the declaration of dividend, with the record date set for August 14, 2026. The company has also approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and has fixed the record date for the purpose of determining entitlement of shareholders for the payment of final dividend for the financial year 2025-26.